Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP1267628.RAUdFvLaphab1z8OBdlb0mCPTt6a-sZNtgkFX-abTzt-I130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP1267628.RAUdFvLaphab1z8OBdlb0mCPTt6a-sZNtgkFX-abTzt-I130_assertion type Assertion NP1267628.RAUdFvLaphab1z8OBdlb0mCPTt6a-sZNtgkFX-abTzt-I130_head.
- NP1267628.RAUdFvLaphab1z8OBdlb0mCPTt6a-sZNtgkFX-abTzt-I130_assertion description "[Diffuse large B-cell lymphoma (DLBCL) is a biologically and clinically heterogeneous disease with marked genomic instability and variable response to conventional R-CHOP (rituximab, cyclophosphamide, doxorubicin, vincristine and prednisone) chemotherapy.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1267628.RAUdFvLaphab1z8OBdlb0mCPTt6a-sZNtgkFX-abTzt-I130_provenance.
- NP1267628.RAUdFvLaphab1z8OBdlb0mCPTt6a-sZNtgkFX-abTzt-I130_assertion evidence source_evidence_literature NP1267628.RAUdFvLaphab1z8OBdlb0mCPTt6a-sZNtgkFX-abTzt-I130_provenance.
- NP1267628.RAUdFvLaphab1z8OBdlb0mCPTt6a-sZNtgkFX-abTzt-I130_assertion SIO_000772 25733167 NP1267628.RAUdFvLaphab1z8OBdlb0mCPTt6a-sZNtgkFX-abTzt-I130_provenance.
- NP1267628.RAUdFvLaphab1z8OBdlb0mCPTt6a-sZNtgkFX-abTzt-I130_assertion wasDerivedFrom befree-2016 NP1267628.RAUdFvLaphab1z8OBdlb0mCPTt6a-sZNtgkFX-abTzt-I130_provenance.
- NP1267628.RAUdFvLaphab1z8OBdlb0mCPTt6a-sZNtgkFX-abTzt-I130_assertion wasGeneratedBy ECO_0000203 NP1267628.RAUdFvLaphab1z8OBdlb0mCPTt6a-sZNtgkFX-abTzt-I130_provenance.